分子診断感染症検査のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Molecular Diagnostics Infectious Disease Testing Market Insights, Forecast to 2028

• レポートコード：QY2207E09253 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の分子診断感染症検査の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に分子診断感染症検査の世界市場のxxx％を占める「細菌感染症検査」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の分子診断感染症検査の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの分子診断感染症検査市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの分子診断感染症検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 分子診断感染症検査のグローバル主要メーカーには、Abbott Laboratories、BD、bioMérieux、Thermo Fisher Scientific、F. Hoffmann-La Roche、Siemens AG、Veridex、Luminex、GenMark Diagnostics、Qiagen NV、Genomix Biotech、BioTheranostics、GenMark Diagnosticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 分子診断感染症検査市場は、種類と用途によって区分されます。世界の分子診断感染症検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査 【用途別セグメント】 病院、実験室研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 分子診断感染症検査製品概要 - 種類別市場（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査） - 用途別市場（病院、実験室研究） - 調査の目的 ・エグゼクティブサマリー - 世界の分子診断感染症検査販売量予測2017-2028 - 世界の分子診断感染症検査売上予測2017-2028 - 分子診断感染症検査の地域別販売量 - 分子診断感染症検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別分子診断感染症検査販売量 - 主要メーカー別分子診断感染症検査売上 - 主要メーカー別分子診断感染症検査価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査） - 分子診断感染症検査の種類別販売量 - 分子診断感染症検査の種類別売上 - 分子診断感染症検査の種類別価格 ・用途別市場規模（病院、実験室研究） - 分子診断感染症検査の用途別販売量 - 分子診断感染症検査の用途別売上 - 分子診断感染症検査の用途別価格 ・北米市場 - 北米の分子診断感染症検査市場規模（種類別、用途別） - 主要国別の分子診断感染症検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの分子診断感染症検査市場規模（種類別、用途別） - 主要国別の分子診断感染症検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の分子診断感染症検査市場規模（種類別、用途別） - 主要国別の分子診断感染症検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の分子診断感染症検査市場規模（種類別、用途別） - 主要国別の分子診断感染症検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの分子診断感染症検査市場規模（種類別、用途別） - 主要国別の分子診断感染症検査市場規模（トルコ、サウジアラビア） ・企業情報 Abbott Laboratories、BD、bioMérieux、Thermo Fisher Scientific、F. Hoffmann-La Roche、Siemens AG、Veridex、Luminex、GenMark Diagnostics、Qiagen NV、Genomix Biotech、BioTheranostics、GenMark Diagnostics ・産業チェーン及び販売チャネル分析 - 分子診断感染症検査の産業チェーン分析 - 分子診断感染症検査の原材料 - 分子診断感染症検査の生産プロセス - 分子診断感染症検査の販売及びマーケティング - 分子診断感染症検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 分子診断感染症検査の産業動向 - 分子診断感染症検査のマーケットドライバー - 分子診断感染症検査の課題 - 分子診断感染症検査の阻害要因 ・主な調査結果

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
Market Analysis and Insights: Global Molecular Diagnostics Infectious Disease Testing Market
The global Molecular Diagnostics Infectious Disease Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Bacterial Infectious Disease Testing accounting for % of the Molecular Diagnostics Infectious Disease Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Molecular Diagnostics Infectious Disease Testing market size is valued at US$ million in 2021, while the North America and Europe Molecular Diagnostics Infectious Disease Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Molecular Diagnostics Infectious Disease Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics Infectious Disease Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics Infectious Disease Testing market.
Global Molecular Diagnostics Infectious Disease Testing Scope and Market Size
Molecular Diagnostics Infectious Disease Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Segment by Application
Hospital
Laboratory Research
By Company
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bacterial Infectious Disease Testing
1.2.3 Viral Infectious Disease Testing
1.2.4 Parasitic Infectious Disease Testing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Perspective (2017-2028)
2.2 Molecular Diagnostics Infectious Disease Testing Growth Trends by Region
2.2.1 Molecular Diagnostics Infectious Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics Infectious Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
3.5 Molecular Diagnostics Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
6.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Type
6.2.1 North America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
6.2.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
6.2.3 North America Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
6.3 North America Molecular Diagnostics Infectious Disease Testing Market Size by Application
6.3.1 North America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
6.3.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
6.3.3 North America Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
6.4 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country
6.4.1 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
6.4.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type
7.2.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
7.2.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
7.2.3 Europe Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application
7.3.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
7.3.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
7.3.3 Europe Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
7.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country
7.4.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
7.4.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type
9.2.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
9.2.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
9.2.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
9.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application
9.3.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
9.3.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
9.3.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
9.4 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country
9.4.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
9.4.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.2.5 BD Recent Developments
11.3 bioMérieux
11.3.1 bioMérieux Company Details
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Molecular Diagnostics Infectious Disease Testing Introduction
11.3.4 bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.3.5 bioMérieux Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Siemens AG
11.6.1 Siemens AG Company Details
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Introduction
11.6.4 Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.6.5 Siemens AG Recent Developments
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.7.5 Veridex Recent Developments
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.8.5 Luminex Recent Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.9.5 GenMark Diagnostics Recent Developments
11.10 Qiagen NV
11.10.1 Qiagen NV Company Details
11.10.2 Qiagen NV Business Overview
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Introduction
11.10.4 Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.10.5 Qiagen NV Recent Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Details
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.11.5 Genomix Biotech Recent Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Details
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.12.5 BioTheranostics Recent Developments
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Details
11.13.2 GenMark Diagnostics Business Overview
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.13.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.13.5 GenMark Diagnostics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Bacterial Infectious Disease Testing
Table 3. Key Players of Viral Infectious Disease Testing
Table 4. Key Players of Parasitic Infectious Disease Testing
Table 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2017-2022)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2023-2028)
Table 11. Molecular Diagnostics Infectious Disease Testing Market Trends
Table 12. Molecular Diagnostics Infectious Disease Testing Market Drivers
Table 13. Molecular Diagnostics Infectious Disease Testing Market Challenges
Table 14. Molecular Diagnostics Infectious Disease Testing Market Restraints
Table 15. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Players (2017-2022)
Table 17. Global Top Molecular Diagnostics Infectious Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2021)
Table 18. Ranking of Global Top Molecular Diagnostics Infectious Disease Testing Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2017-2022)
Table 26. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2023-2028)
Table 28. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Application (2017-2022)
Table 30. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Application (2023-2028)
Table 32. North America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product
Table 65. Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 66. Abbott Laboratories Recent Developments
Table 67. BD Company Details
Table 68. BD Business Overview
Table 69. BD Molecular Diagnostics Infectious Disease Testing Product
Table 70. BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 71. BD Recent Developments
Table 72. bioMérieux Company Details
Table 73. bioMérieux Business Overview
Table 74. bioMérieux Molecular Diagnostics Infectious Disease Testing Product
Table 75. bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 76. bioMérieux Recent Developments
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product
Table 80. Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Developments
Table 82. F. Hoffmann-La Roche Company Details
Table 83. F. Hoffmann-La Roche Business Overview
Table 84. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product
Table 85. F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 86. F. Hoffmann-La Roche Recent Developments
Table 87. Siemens AG Company Details
Table 88. Siemens AG Business Overview
Table 89. Siemens AG Molecular Diagnostics Infectious Disease Testing Product
Table 90. Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 91. Siemens AG Recent Developments
Table 92. Veridex Company Details
Table 93. Veridex Business Overview
Table 94. Veridex Molecular Diagnostics Infectious Disease Testing Product
Table 95. Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 96. Veridex Recent Developments
Table 97. Luminex Company Details
Table 98. Luminex Business Overview
Table 99. Luminex Molecular Diagnostics Infectious Disease Testing Product
Table 100. Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 101. Luminex Recent Developments
Table 102. GenMark Diagnostics Company Details
Table 103. GenMark Diagnostics Business Overview
Table 104. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 105. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 106. GenMark Diagnostics Recent Developments
Table 107. Qiagen NV Company Details
Table 108. Qiagen NV Business Overview
Table 109. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product
Table 110. Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 111. Qiagen NV Recent Developments
Table 112. Genomix Biotech Company Details
Table 113. Genomix Biotech Business Overview
Table 114. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product
Table 115. Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 116. Genomix Biotech Recent Developments
Table 117. BioTheranostics Company Details
Table 118. BioTheranostics Business Overview
Table 119. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product
Table 120. BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 121. BioTheranostics Recent Developments
Table 122. GenMark Diagnostics Company Details
Table 123. GenMark Diagnostics Business Overview
Table 124. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 125. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 126. GenMark Diagnostics Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type: 2021 VS 2028
Figure 2. Bacterial Infectious Disease Testing Features
Figure 3. Viral Infectious Disease Testing Features
Figure 4. Parasitic Infectious Disease Testing Features
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Laboratory Research Case Studies
Figure 8. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 9. Global Molecular Diagnostics Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Molecular Diagnostics Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region: 2021 VS 2028
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players in 2021
Figure 13. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
Figure 15. North America Molecular Diagnostics Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 17. North America Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 18. North America Molecular Diagnostics Infectious Disease Testing Market Size Share by Country (2017-2028)
Figure 19. United States Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Molecular Diagnostics Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 23. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 24. Europe Molecular Diagnostics Infectious Disease Testing Market Size Share by Country (2017-2028)
Figure 25. Germany Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size Share by Region (2017-2028)
Figure 35. China Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Molecular Diagnostics Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Molecular Diagnostics Infectious Disease Testing Market Size Share by Country (2017-2028)
Figure 45. Mexico Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size Share by Country (2017-2028)
Figure 51. Turkey Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 55. BD Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 56. bioMérieux Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 59. Siemens AG Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 60. Veridex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 61. Luminex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 62. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 63. Qiagen NV Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 64. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 65. BioTheranostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 66. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---